Biomarin Pharmaceutical Inc (BMRN)

76.93 +1.42  +1.88% NASDAQ May 14, 20:00 USD
View Full Chart
Price Chart
View All BMRN News

News

View All Events

Events

Date Type Description
08/04/2021 00:00 Earnings Results Q2 2021 Earnings Results
08/04/2021 16:30 Earnings Calls Q2 2021 Earnings Call
04/29/2021 00:00 Earnings Results Q1 2021 Earnings Results
04/29/2021 16:30 EDT Earnings Calls Q1 2021 Earnings Call
02/25/2021 00:00 Earnings Results Q4 2020 Earnings Results
02/25/2021 16:30 EST Earnings Calls Q4 2020 Earnings Call
11/05/2020 00:00 Earnings Results Q3 2020 Earnings Results
11/05/2020 16:30 EST Earnings Calls Q3 2020 Earnings Call
08/04/2020 16:30 EDT Earnings Calls Q2 2020 Earnings Call
08/04/2020 00:00 Earnings Results Q2 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.
  • URL: http://www.bmrn.com
  • Investor Relations URL: http://investors.bmrn.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Mid Cap/Growth
  • Next Earnings Release: Aug. 04, 2021
  • Last Earnings Release: Apr. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 5.24%
FBT First Trust NYSE Arca Biotech ETF 3.22%
BBH VanEck Vectors Biotech ETF 2.81%
VHCOX Vanguard Capital Opportunity Inv 2.19%
APSRX Fiera Capital Small/Mid-Cap Growth Inv 1.84%
FXH First Trust Health Care AlphaDEX® ETF 1.80%
RYCFX Rydex Biotechnology C 1.61%
HQH Tekla Healthcare Investors 1.51%
POGRX PRIMECAP Odyssey Growth 1.38%
POAGX PRIMECAP Odyssey Aggressive Growth 1.32%
IBB iShares Nasdaq Biotechnology ETF 1.20%
CAFFX American Funds AMCAP 529F1 0.93%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.